The standardised tumour mutation burden (TMB) analysis is shown in Figure 3A, where NFE2L2, NOTCH1, SYNE2, FAT3, PAPPA2 and FMN2 showed lower mutation frequencies in the low‐risk corner. Here, FMN2 is linked to neoplasm.